Really good. Clinically dead does not mean that the life force has left the body yet. Thus actually repairing the damage is quite practical and well worth doing. In fact this is an excellent time to do as much repair as possible.
Then bring the person back to consciousness while stabilizing all aspects of the biochemistry.
This is a beginning but it leads to complete body restoration so long as significant cell death has not taken place.
.
New Clinical Trial Will Attempt to Bring Dead Humans Back to Life
Could we regenerate brains in clinically dead patients? A health
watchdog organization has approved a new trial that will attempt to
revive technically dead humans using their own stem cells.
The trial will be run by biotech company Bioquark,
which is primarily focused on developing "combinatorial biologics" that
get to the heart of disease reversal rather than just treating the
symptoms. They believe that stem cells can be used as a kind of "reset
button" for the body, erasing cell damage and stimulating tissue
regeneration. They claim that their research could potentially lead to
"complex tissue and organ regeneration, disease reversion, and even
biological age reversal."
In this study, twenty patients
who are declared braindead (which is considered clinical death, so long
as the patient is only kept alive through life support), will be
subjected to a series of treatments, including the injection of brain
stem cells and peptides into the brain. The researchers hypothesize that
the stem cells will take their cue from surrounding cells and
differentiate into fully functional brain cells, a process that has been
seen in other animals, such as salamanders that regrow limbs.
"This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime," Dr Ira Pastor, the CEO of Bioquark, told The Telegraph. "To undertake such a complex initiative, we are combining biologic regenerative medicine tools with other existing medical devices typically used for stimulation of the central nervous system, in patients with other severe disorders of consciousness.
We hope to see results within the first two to three months."
The
first stage, since it has such a small and non-random sample size, will
just be a proof-of-concept. The cocktail of stem cells and peptides
will be administered bi-weekly over the course of six weeks.
"It
is a long term vision of ours that a full recovery in such patients is a
possibility, although that is not the focus of this first study – but
it is a bridge to that eventuality."
Some
scientists are already expressing doubt that this could lead to
anything resembling a genuine recovery for braindead patients, as
studies have shown that humans' capacity for regeneration is somewhat
limited. However, even if the regeneration aspect of the project isn't
quite successful, the study will still shed light on the process of
brain death, and possibly spur innovation in the treatment of
debilitating neurological diseases.
"Through our study, we will gain unique insights into the state of human brain death, which will have important connections to future therapeutic development for other severe disorders of consciousness, such as coma, and the vegetative and minimally conscious states, as well as a range of degenerative CNS conditions, including Alzheimer's and Parkinson's disease," said Dr Sergei Paylian, Founder, President, and Chief Science Officer of Bioquark.
No comments:
Post a Comment